CLICK IMAGES TO DOWNLOAD REPORTS

4Q19
EXELIXIS (EXEL): CABOZANTINIB IN RENAL CELL CARCINOMA 
​

3Q19
NON-SMALL CELL LUNG CANCER (NSCLC) MARKET
​

3Q19
​SOLID TUMOR - GREATER ROLE FOR PARP INHIBITORS
​

3Q19
​COMPETITIVE POSITIONING IN HEMATOLOGIC CANCER - LYMPHOMA​

LARGE-CAP PHARMA/BIOTECH

Symbol	Manufacturer	Viola Advisory Rating	Viola Advisory PT
RHHBY	Roche	Buy	44.00
MRK	Merck & Co.	Buy	93.00
PFE	Pfizer Inc.	Buy	43.00
NVS	Novartis AG	Buy	100.00
AMGN	Amgen Inc.	Buy	235.00
BMY	Bristol-Myers	Buy	67.00
AZN	AstraZeneca plc	Buy	55.00
LLY	Eli Lilly and Co.	Buy	122.00
CLVS	Clovis Oncology	Hold	13.00

Source: Yahoo Finance, YCharts.com and Viola Advisory, LLC

BIOTECH SMIDs

Symbol	Manufacturer	Viola Advisory Rating	Viola Advisory PT
IONS	Ionis Pharmaceuticals	Buy	70.00
ALNY	Alnylam Pharmaceuticals	Hold	120.00
SRPT	Sarepta Therapeutics	Buy	140.00
NKTR	Nektar Therapeutics	Hold	25.00
SGEN	Seattle Genetics	Buy	125.00
IOVA	Iovance Biotherapeutics	Hold	30.00

Source: Yahoo Finance, YCharts.com and Viola Advisory, LLC

2Q19
IOVANCE BIOTHERAPEUTICS
​(IOVA)

2Q19
SEATTLE GENETICS
​(SGEN)​

1Q19
SANGAMO THERAPEUTICS
​(SGMO)

1Q19
IONIS PHARMACEUTICALS (IONS) &
​ALNYLAM PHARMACEUTICALS (ALNY)

1Q19
​SAREPTA
​THERAPEUTICS
​(SRPT)

1Q19
​NEKTAR
​THERAPEUTICS
​(NKTR)

PHARMA/BIOTECH
​4Q18 EARNINGS

PHARMA/BIOTECH INITIATION
​& 3Q18 EARNINGS

DRUG SUPPLY CHAIN

2Q18
​RETAIL PHARMACY/PBM

1Q18
​RETAIL PHARMACY/PBM

1Q18
​DRUG WHOLESALERS

1Q18
​HEALTH PAYERS

---

RETAIL PHARMACY INITIATION
​& 4Q17 EARNINGS

HEALTHCARE MERGERS (CVS/Aetna & Cigna/ESRX):
​PUTS & TAKES